To our knowledge, the present study is the first prospective validation of quantitative CEA mRNA detection in peritoneal washes as a reliable prognostic indicator of peritoneal recurrence in the clinical setting for gastric cancer patients. The gene discussed is CEACAM5; the disease is gastric cancer.